Andrew Hantel

1.6k total citations
60 papers, 499 citations indexed

About

Andrew Hantel is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Oncology. According to data from OpenAlex, Andrew Hantel has authored 60 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Public Health, Environmental and Occupational Health, 22 papers in Economics and Econometrics and 11 papers in Oncology. Recurrent topics in Andrew Hantel's work include Health Systems, Economic Evaluations, Quality of Life (20 papers), Ethics in Clinical Research (13 papers) and Economic and Financial Impacts of Cancer (11 papers). Andrew Hantel is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (20 papers), Ethics in Clinical Research (13 papers) and Economic and Financial Impacts of Cancer (11 papers). Andrew Hantel collaborates with scholars based in United States, United Kingdom and Australia. Andrew Hantel's co-authors include Gregory A. Abel, Wendy Stock, Harvey M. Golomb, Jason X. Cheng, Thomas F. Gajewski, Jonathan M. Marron, Kristen Wroblewski, Mark Siegler, Richard A. Larson and Yichen Wang and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Andrew Hantel

53 papers receiving 487 citations

Peers

Andrew Hantel
C.A. Uyl-de Groot Netherlands
Anna Moseley United States
Justine M. Kahn United States
Anderson B. Collier United States
Binay Kumar Shah United States
Jane Jijun Liu United States
Ze Cong United States
C.A. Uyl-de Groot Netherlands
Andrew Hantel
Citations per year, relative to Andrew Hantel Andrew Hantel (= 1×) peers C.A. Uyl-de Groot

Countries citing papers authored by Andrew Hantel

Since Specialization
Citations

This map shows the geographic impact of Andrew Hantel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Hantel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Hantel more than expected).

Fields of papers citing papers by Andrew Hantel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Hantel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Hantel. The network helps show where Andrew Hantel may publish in the future.

Co-authorship network of co-authors of Andrew Hantel

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Hantel. A scholar is included among the top collaborators of Andrew Hantel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Hantel. Andrew Hantel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hibbs, Stephen P., et al.. (2025). The Duffy antigen: A narrative review of testing, epidemiology, neutrophil counts and clinical consequences. British Journal of Haematology. 207(3). 737–749. 1 indexed citations
2.
Wang, Yating, Angel M. Cronin, Elad Sharon, et al.. (2025). Duffy Null–Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility. JAMA Oncology. 11(12). 1540–1540. 1 indexed citations
3.
Hantel, Andrew, Emily Senay, Fay J. Hlubocky, et al.. (2025). The ethics of climate change and health-care delivery: a national survey of US-based physicians. The Lancet Planetary Health. 9(8). 101289–101289.
4.
Hantel, Andrew, Emily Senay, Cristina Richie, et al.. (2024). A focus group study of ethical issues during climate-informed health decision-making. Nature Climate Change. 14(10). 1040–1046. 10 indexed citations
5.
Hantel, Andrew, Yating Wang, Ivy Abraham, et al.. (2024). Identifying eligibility criteria that perpetuate race/ethnic disparities in acute myeloid leukemia (AML) clinical trial participation.. Journal of Clinical Oncology. 42(16_suppl). 1589–1589.
6.
Patel, Kishan, et al.. (2024). Patient-Reported Outcomes in Phase 3 Clinical Trials for Blood Cancers: A Systematic Review. JAMA Network Open. 7(6). e2414425–e2414425. 6 indexed citations
7.
Hibbs, Stephen P., Kruti Bhagirath Vora, Vanessa Apea, et al.. (2024). Cancer Trial Eligibility and Therapy Modifications for Individuals With Duffy Null–Associated Neutrophil Count. JAMA Network Open. 7(9). e2432475–e2432475. 4 indexed citations
8.
Hantel, Andrew, Thomas Walsh, Jonathan M. Marron, et al.. (2024). Perspectives of Oncologists on the Ethical Implications of Using Artificial Intelligence for Cancer Care. JAMA Network Open. 7(3). e244077–e244077. 21 indexed citations
9.
Marron, Jonathan M., et al.. (2024). Shifting from Equality toward Equity: Addressing Disparities in Research Participation for Clinical Cancer Research. The Journal of Clinical Ethics. 35(1). 8–22.
10.
Kohlschmidt, Jessica, Krzysztof Mrózek, Deedra Nicolet, et al.. (2023). Association of social deprivation with survival in younger adult patients with AML: an Alliance study. Blood Advances. 7(15). 4019–4023. 5 indexed citations
11.
Hantel, Andrew, Rebecca Spence, Angela R. Bradbury, et al.. (2023). ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages. Journal of Clinical Oncology. 42(3). 358–365. 5 indexed citations
12.
Hantel, Andrew, Marlise R. Luskin, Irum Khan, et al.. (2023). Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia. Haematologica. 109(4). 1046–1052. 5 indexed citations
13.
Abel, Gregory A., Haesook T. Kim, Andrew Hantel, et al.. (2021). Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?. Leukemia. 35(4). 1223–1223. 1 indexed citations
14.
Abel, Gregory A., Haesook T. Kim, Andrew Hantel, et al.. (2020). Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?. Leukemia. 35(4). 1166–1175. 6 indexed citations
15.
Hantel, Andrew, et al.. (2020). US State Government Crisis Standards of Care Guidelines. JAMA Oncology. 7(2). 199–199. 5 indexed citations
16.
Tseng, Jennifer F., Erin S. DeMartino, Paul S. Mueller, et al.. (2019). Decisional Incapacity and the Prevalence of Surrogate Decision Makers. SSRN Electronic Journal.
17.
18.
Hantel, Andrew, Wendy Stock, & Satyajit Kosuri. (2018). Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing Clinician. Clinical Lymphoma Myeloma & Leukemia. 18(10). 636–647. 5 indexed citations
19.
Hantel, Andrew, et al.. (2018). Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab. Journal for ImmunoTherapy of Cancer. 6(1). 73–73. 51 indexed citations
20.
Nabhan, Chadi, Sonali M. Smith, Irene Helenowski, et al.. (2011). Analysis of very elderly (≥80 years) non‐hodgkin lymphoma: impact of functional status and co‐morbidities on outcome. British Journal of Haematology. 156(2). 196–204. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026